5-oxo-prolyl-glycyl-arginine-4-nitroanilide and Central Nervous System Neoplasm

5-oxo-prolyl-glycyl-arginine-4-nitroanilide has been researched along with Central Nervous System Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamasuna, R; Iseda, T; Kataoka, H; Koono, M; Moriyama, T; Nakano, S; Sameshima, T; Wakisaka, S; Yokogami, K; Yoshida, E	1

Other Studies

1 other study(ies) available for 5-oxo-prolyl-glycyl-arginine-4-nitroanilide and Central Nervous System Neoplasm

Article	Year
Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells. Clinical & experimental metastasis, 1999, Volume: 17, Issue:10 Topics: Central Nervous System Neoplasms; Glioma; Hepatocyte Growth Factor; Humans; Oligopeptides; Proto-Oncogene Proteins c-met; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Tumor Cells, Cultured; Up-Regulation; Urokinase-Type Plasminogen Activator	1999

Article

Year

Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.

Clinical & experimental metastasis, 1999, Volume: 17, Issue:10

Topics: Central Nervous System Neoplasms; Glioma; Hepatocyte Growth Factor; Humans; Oligopeptides; Proto-Oncogene Proteins c-met; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Tumor Cells, Cultured; Up-Regulation; Urokinase-Type Plasminogen Activator

1999